Events Add an event Speakers Talks Collections
 

Speakers

Sort by
Newest
Trending
1-30 of 67
1-30 of 67
Filter
Todd Harrison
Founding Partner & Chief Investment Officer at CB1 Capital Management
asset, balance sheet, benzinga cannabis capital conference 2021, benzinga insights, board of directors, brand, cannabis 2021, cannabis entrepreneurs , cannabis event 2021, cannabis indica, cannabis investor , cannabis opportunities , cannabis sativa, cost of capital, earnings before interest, taxes, depreciation and amortization, financial adviser, governance, infrastructure, initial public offering, institutional investor, investor, legal cannabis industry , market (economics), market liquidity, mergers and acquisitions, price, private equity, return on investment, speculation, stock, synergy, tax, valuation (finance)
Emily Paxhia
Co-founder and Managing Partner at Poseidon
asset, balance sheet, benzinga cannabis capital conference 2021, benzinga insights, big data, board of directors, brand, cannabis 2021, cannabis entrepreneurs , cannabis event 2021, cannabis indica, cannabis investor , cannabis opportunities , cannabis sativa, capital market, cost of capital, democratic party (united states), earnings before interest, taxes, depreciation and amortization, economics, economy, entrepreneurship, financial adviser, foreign direct investment, governance, hedge fund, infrastructure, initial public offering, institutional investor, investment, investment banking, investor, legal cannabis industry , mark-to-market accounting, market (economics), market liquidity, mergers and acquisitions, montana, mutual fund, perception, policy, price, private equity, profit (economics), return on investment, special-purpose acquisition company, speculation, stock, synergy, tax, u.s. state, unemployment, valuation (finance)
Sean Stiefel
CEO/Founder at Navy Capital
asset, balance sheet, bank, benzinga cannabis capital conference 2021, benzinga insights, board of directors, brand, business, cannabidiol, cannabis (drug), cannabis 2021, cannabis entrepreneurs , cannabis event 2021, cannabis indica, cannabis investor , cannabis opportunities , cannabis sativa, capital market, corporate governance, cost of capital, cvs pharmacy, debt, distracted driving, earnings before interest, taxes, depreciation and amortization, feeling, financial adviser, governance, great depression, hedge fund, horror film, infrastructure, initial public offering, institutional investor, investor, legal cannabis industry , market (economics), market liquidity, mergers and acquisitions, money, morgan stanley, price, private equity, privately held company, pub, return on investment, shenzhen, speculation, stock, synergy, target corporation, tax, tiger management, united states, valuation (finance), walgreens
John Lykouretzos
CEO at FocusGrowth Asset Management
asset, balance sheet, benzinga cannabis capital conference 2021, benzinga insights, board of directors, brand, cannabis 2021, cannabis entrepreneurs , cannabis event 2021, cannabis indica, cannabis investor , cannabis opportunities , cannabis sativa, cost of capital, earnings before interest, taxes, depreciation and amortization, financial adviser, governance, infrastructure, initial public offering, institutional investor, investor, legal cannabis industry , market (economics), market liquidity, mergers and acquisitions, price, private equity, return on investment, speculation, stock, synergy, tax, valuation (finance)
James Mish
CEO at 22nd Century Group
22nd century group, benzinga insights, brand, british empire, business model, cannabinoid, cannabis, cannabis (drug), cannabis conference 2021, cannabis entrepreneurs , cannabis event 2021, cannabis indica, cannabis investor , cannabis investor presentation , cannabis news 2021, cigarette, diet drink, dietary supplement, food, food and drug administration, franchising, genetically modified food, harm reduction, intel, james mish, legal cannabis industry , medication, nicotine, plant breeding, sea, smoking, strain (biology), synthetic cannabinoids, tetrahydrocannabinol, tobacco smoking, trading strategies cannabis
Javier Hasse
Managing Director at Benzinga Cannabis
401(k), advertising, agnosticism, android (operating system), asset, aurora cannabis, balance sheet, banana, bank, benzinga cannabis capital conference 2021, benzinga insights, billboard, black–scholes model, board of directors, brand, budget, business model, business-to-business, california, canada, cannabidiol, cannabis, cannabis (drug), cannabis 2021, cannabis conference 2021, cannabis entrepreneurs , cannabis event 2021, cannabis indica, cannabis industry, cannabis investor , cannabis market growth, cannabis opportunities , cannabis organizations, cannabis sativa, capital (economics), celebrity, chocolate, collateral (finance), colorado, competition, consolidation (business), construction of electronic cigarettes, cost, cost of capital, culture, customer, debt, drink, drug, earnings before interest, taxes, depreciation and amortization, ecosystem, electricity, electronic cigarette, employment, energy, entrepreneurship, europe, experience, facebook, federal reserve, fee, financial adviser, financial technology, financial transaction, fintech awards, flower, food, goal, governance, great recession, greenhouse, heating, ventilation, and air conditioning, hedge fund, humidity, hybrid (biology), hydroponics, infrastructure, initial public offering, instagram, institutional investor, interest, interstate highway system, investment, investment banking, investor, judy rinkus , knowledge, las vegas, latin america, law, leadership, leaf, leaseback, legal cannabis industry , leverage (finance), license, lighting, loan, market (economics), market liquidity, maryland, medical research, mergers and acquisitions, mexico, mobile app, money, motivation, new york city, new york stock exchange, option (finance), organization, organizational culture, otc markets group, payment, pennsylvania, pharmacy, phoenix, arizona, plant, price, private equity, proposition, public company, purchase order, real estate investment trust, reason, research, research and development, retail, return on investment, science, security (finance), seed to sale funding , share price, social media, social network, spain, speculation, stakeholder (corporate), startup company, stock, stock exchange, stock market, switch, synergy, tax, temperature, terpene, tetrahydrocannabinol, theory, tourism, tuberculosis, united states, valuation (finance), value proposition, ventilation (architecture), venture capital, vertical integration, virginia, water, writer
Joanna Matson-Tandberg
Founder & CEO at ZVEDA Botanicals
asthma, ayurveda, breast milk, cannabidiol, cannabis (drug), cannabis indica, curiosity, dose (biochemistry), eating disorder, epilepsy, feeling, hemp, immune system, infection, medicine, nausea, physician, prednisone, pregnancy, snowboarding, streptococcal pharyngitis, sulfonamide (medicine), tetrahydrocannabinol, tonsillectomy
Ratchakrit Ekamorndilok
Advisor to the chairman at THG International
adherence (medicine), ageing, aquaponics, autism, brain, cancer, cannabidiol, cannabis, cannabis (drug), cannabis indica, deep water culture, disease, ebb and flow, fish oil, food and drug administration, genetics, genotype, good manufacturing practice, gregor mendel, hash oil, health care, health claim, hemp, hybrid (biology), hydroponics, male, medical cannabis, medication, medicine, miracle, mitochondrion, neurology, papaya, pharmaceutical industry, pharmacist, phenotype, physician, regulatory compliance, reproduction, science, sea, sex, sex linkage, soybean, strain (biology), tetrahydrocannabinol, vegetable, water
Priscilla Agoncillo
Co-Founder at Original Breeders League
agriculture, anti-inflammatory, antidepressant, anxiolytic, autism, belief, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, clinical trial, consciousness, cotton, crispr, crispr gene editing, democratic party (united states), disease, dispensary, dna, dna sequencing, dominance (genetics), dose (biochemistry), dravet syndrome, dronabinol, education, emergency medical technician, endocannabinoid system, entourage effect, epilepsy, ethnobotany, food and drug administration, free market, gene, gene mapping, genetic engineering, genetically modified organism, genetics, genome, gerrymandering, good manufacturing practice, hair loss, hashish, health, health care, hemp, human genome, landrace, major depressive disorder, management of depression, mdma, mechanism of action, medical cannabis, medication, medicine, mental disorder, mental health, micropropagation, mood stabilizer, neuroplasticity, neurotransmitter, neutron, organism, paramedic, pediatrics, pharmaceutical industry, pharmacology, pharmacy, plant tissue culture, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychiatry, psychoactive drug, psychology, schizophrenia, science, selective serotonin reuptake inhibitor, sense, sequencing, serotonin, substance dependence, swing state, syndrome, tetrahydrocannabinol, tony montana, treatment-resistant depression, whole genome sequencing
Ekapol Limpongsa
Rangsit University at College of Pharmacy
adverse effect, agriculture, analgesic, angiogenesis, apoptosis, blastoma, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis indica, cannabis sativa, chemotherapy, clinical trial, computer security, dose (biochemistry), drug, effects of cannabis, euphoria, food and drug administration, forecasting, insomnia, medical cannabis, medication, metastasis, opioid, pain, pain management, pharmacy, physician, post-traumatic stress disorder, psychiatrist, psychology, psychotherapy, public company, question, science, technology, tetrahydrocannabinol, the hallmarks of cancer, treatment of cancer, water
Chaowalit Monton
Lecturer of College of Pharmacy at Rangsit University
adverse effect, analgesic, angiogenesis, apoptosis, blastoma, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis indica, cannabis sativa, chemotherapy, effects of cannabis, euphoria, insomnia, medical cannabis, metastasis, opioid, pain, pharmacy, tetrahydrocannabinol, the hallmarks of cancer, treatment of cancer
Surang Leelawat
Director at Medicinal Cannabis research Institute
adverse effect, analgesic, angiogenesis, apoptosis, blastoma, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis indica, cannabis sativa, chemotherapy, effects of cannabis, euphoria, insomnia, medical cannabis, metastasis, opioid, pain, pharmacy, tetrahydrocannabinol, the hallmarks of cancer, treatment of cancer
Debra Smith-Torrence
CEO and Founder at Auspicious Wellness CBD Products and Distribution
agriculture, authorize.net, bill (law), cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, celebrity, chromatography, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug enforcement administration, drug test, facebook, food, food and drug administration, good manufacturing practice, health food, hemp, indiana general assembly, instagram, irrigation, karen tallian, knowledge, license, linkedin, medical cannabis, mind, nutraceutical, pharmaceutical industry, placebo-controlled study, qr code, reading (legislature), reason, research, science, target audience, terpene, tetrahydrocannabinol, the new york times, united states senate, veto, water, youtube
Liz Geisleman
Vice President at Rocky Mountain Reagents
advertising, anti-inflammatory, brand, budtender, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, class action, damages, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug, drug enforcement administration, false advertising, federal trade commission, food, food and drug administration, good manufacturing practice, hemp, instagram, law, lawsuit, license, linkedin, medical cannabis, medication, new drug application, nutraceutical, pharmaceutical industry, pharmacy, product testing, qr code, regulatory compliance, social media, target audience, terpene, tetrahydrocannabinol, youtube
Ryan McFarland
CEO at WhereZHemp
aphria (company), brand, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, coffee, convertible bond, cosmetics, crowdfunding, debenture, debt, delta-8-tetrahydrocannabinol, dietary supplement, discounting, distribution (marketing), dose (biochemistry), drug enforcement administration, financial capital, flavor, food, food and drug administration, good manufacturing practice, health claim, hemp, instagram, interest, interest rate, investment, investor, kool-aid, license, linkedin, marketplace, medical cannabis, mergers and acquisitions, mountain dew, nestea, novel food, nutraceutical, option (finance), organic certification, pharmaceutical industry, pharmacy, prescription drug, pricing, qr code, recycling, retail, shelf life, soft drink, stock, stock dilution, target audience, tea, terpene, tetrahydrocannabinol, toast (honor), valuation (finance), youtube
Ricky Chandler
Co-Founder at CBD WIILLY
cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug enforcement administration, food and drug administration, good manufacturing practice, hemp, instagram, license, linkedin, medical cannabis, nutraceutical, pharmaceutical industry, qr code, target audience, terpene, tetrahydrocannabinol, youtube
Rebecca Zirkle
Owner & Founder at Cultivate Hope Chemovar
cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, delta-8-tetrahydrocannabinol, dietary supplement, dose (biochemistry), drug enforcement administration, food and drug administration, good manufacturing practice, hemp, instagram, license, linkedin, medical cannabis, nutraceutical, pharmaceutical industry, qr code, target audience, terpene, tetrahydrocannabinol, youtube
Tommy Chong
Canadian-American actor
amnesia, brand, british columbia, canada, cannabis, cannabis indica, cannabis sativa, car, energy, feeling, god, jury, lawyer, learning, legend, luck, memory, money, myth, reason, street, survival of the fittest, tommy chong, universe
Doug Benson
Comedian
apartment, austin, texas, cannabis, cannabis indica, doug benson, forward (association football), grateful dead, headphones, mexico, movie theater, nogales, arizona, passport, police, prison, question, rock music, sacramento, california, street, texas, tommy chong, truth, tucson, arizona, understanding, weed
John Salley
Co-Founder at DEUCES 22
1992 united states men's olympic basketball team, atlantic coast conference, bear, bill gates, brand, brand loyalty, cannabis, cannabis (drug), cannabis culture, cannabis indica, celebrity, coca-cola, compassion, computer, david icke, dennis rodman, detroit pistons, diet (nutrition), eddie murphy, elvis presley, entrepreneurship, eyelash, feeling, independent school, john salley, joke, kobe bryant, michael jackson, michael jordan, mind, money, muhammad ali, phil jackson, plant, prejudice, real estate, reality, reason, retail, scottie pippen, shaquille o'neal, the coca-cola company, thought, tommy chong, tony the tiger, understanding, veganism, vineyard, wind, zürich
Rick Sanders
Technical Sales at Thar Process: FDA Registered Extraction / Purification Services & Equipment: SFE + SFC (CE, UL, CSA)
bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis indica, cannabis sativa, cannabis strain, chromatography, drug test, entourage effect, environmental remediation, ethanol, fertilizer, freeze-drying, hexane, high-performance liquid chromatography, isopropyl alcohol, solution, supercritical carbon dioxide, supercritical fluid, tetrahydrocannabinol, water
Jourdan Woltz
Owner at JADE Healing Co CBD
antidepressant, autism, belief, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis indica, cannabis sativa, cannabis strain, chromatography, dose (biochemistry), dronabinol, drug test, entourage effect, environmental remediation, ethanol, fertilizer, freeze-drying, health care, hexane, high-performance liquid chromatography, isopropyl alcohol, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, solution, substance dependence, supercritical carbon dioxide, supercritical fluid, tetrahydrocannabinol, treatment-resistant depression, water
Chip Paul
President & Co-Founder at GnuPharma
alternative medicine, alzheimer's disease, antidepressant, antipsychotic, appetite, autism, autoimmune disease, belief, bioavailability, bipolar disorder, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cattle feeding, certificate of analysis, chemotherapy, consumer protection, depression (mood), dietary supplement, docosahexaenoic acid, dopamine, dose (biochemistry), dronabinol, drug development, eating, eicosapentaenoic acid, emergency medical technician, emulsion, endocannabinoid system, endocrinology, epilepsy, fat, fibromyalgia, fish oil, food and drug administration, gpr55, health care, hormone, hunger (physiology), hypertension, hypothalamus, irritable bowel syndrome, major depressive disorder, management of depression, mdma, medical cannabis, medicine, mental health, mood stabilizer, nonverbal communication, norepinephrine, obesity, omega-3 fatty acid, omega-6 fatty acid, paracetamol, parkinson's disease, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, pharmacy, placebo, post-traumatic stress disorder, prescription drug, probiotic, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, selective serotonin reuptake inhibitor, serotonin, shelf life, sleep, substance dependence, synthetic cannabinoids, tablet (pharmacy), tetrahydrocannabinol, topical medication, traditional chinese medicine, treatment-resistant depression, triglyceride, trpv1, vitamin c, well-being
Israel Garcia
Director Of Chemistry at Bayou City Hemp Company
bioavailability, brand, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, emulsion, endocannabinoid system, food and drug administration, health, human, ibuprofen, memory, omega-3 fatty acid, omega-6 fatty acid, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, rapid eye movement sleep, route of administration, shelf life, sleep, solution, tablet (pharmacy), tetrahydrocannabinol, transparency and translucency
Chris Cooper
Founder and CEO at Lucent Botanicals
anti-inflammatory, aromatherapy, aromaticity, behavior, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, chromium, dietary supplement, dose (biochemistry), drink, entourage effect, epilepsy, essential oil, food, food and drug administration, good manufacturing practice, hemp, herbal distillate, herbal medicine, hindsight bias, juice, lemon, ligand (biochemistry), limonene, mango, medication, medicine, mind, pharmaceutical industry, route of administration, secondary metabolite, spectrum, synergy, terpene, terpenoid, tetrahydrocannabinol, time, traditional chinese medicine, water, water activity
anti-inflammatory, antidepressant, aromatherapy, autism, behavior, belief, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, dose (biochemistry), drink, dronabinol, entourage effect, essential oil, health care, herbal distillate, hindsight bias, juice, lemon, limonene, major depressive disorder, management of depression, mango, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, secondary metabolite, selective serotonin reuptake inhibitor, spectrum, substance dependence, terpene, terpenoid, tetrahydrocannabinol, treatment-resistant depression, water, water activity
Annie Epley
Director of Operations at From Soil to Soul, LLC
anti-inflammatory, antidepressant, aromatherapy, autism, behavior, belief, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis indica, cannabis sativa, dose (biochemistry), drink, dronabinol, entourage effect, essential oil, health care, herbal distillate, hindsight bias, juice, lemon, limonene, major depressive disorder, management of depression, mango, mdma, medical cannabis, medicine, mental health, mood stabilizer, pharmaceutical industry, pharmacy, psilocybin, psychedelic drug, psychiatry, psychoactive drug, psychology, secondary metabolite, selective serotonin reuptake inhibitor, spectrum, substance dependence, terpene, terpenoid, tetrahydrocannabinol, treatment-resistant depression, water, water activity
Michael Chang
Medical Director at Nutex Health
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anti-inflammatory, anticoagulant, antipsychotic, appetite, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, bronchodilator, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis industry, cannabis sativa, cannabis strain, cerebellum, certificate of analysis, chemical synapse, chronic condition, chronic fatigue syndrome, depression (mood), diabetes, dispensary, dopamine, dose (biochemistry), dravet syndrome, drug, drug enforcement administration, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, family medicine, fibromyalgia, food and drug administration, free market, gateway drug effect, good manufacturing practice, gpr55, hair loss, heartburn, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medication, medicine, mental disorder, mental health, methotrexate, morphine, national health service, nervous system, norepinephrine, nursing, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, personalized medicine, pharmaceutical industry, pharmacology, pharmacy, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, pulmonary fibrosis, randomized controlled trial, residency (medicine), rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, self-medication, serotonin, spasticities, sports medicine, sympathetic nervous system, symptom, synapse, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vagus nerve, vagus nerve stimulation, vaporizer (inhalation device), warfarin
Jeff Konin
Clinical Professor at College of Nursing & Health Sciences at Florida International University
arthritis, bioavailability, brand, budtender, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, carbamazepine, chemistry, consumer protection, cytochrome p450, dietary supplement, dose (biochemistry), dream, drug development, effects of cannabis, emergency department, emulsion, endocannabinoid system, fibromyalgia, food and drug administration, gpr55, health, homeostasis, human, hydroxychloroquine, ibuprofen, medical school, medicine, memory, morphine, omega-3 fatty acid, omega-6 fatty acid, opiate, paracetamol, petroleum, pharmaceutical formulation, pharmaceutical industry, pharmacokinetics, pharmacology, placebo, psilocybin mushroom, randomized controlled trial, rapid eye movement sleep, route of administration, shelf life, sleep, solution, sports medicine, tablet (pharmacy), tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, transparency and translucency, vaporizer (inhalation device)
1 2 3
1-30 of 67